| DNMT3A Mutations in Acute Myeloid Leukemia TJ Ley, L Ding, MJ Walter, MD McLellan, T Lamprecht, DE Larson, ... New England Journal of Medicine 363 (25), 2424-2433, 2010 | 2037 | 2010 |
| Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ... Nature 515 (7528), 577-581, 2014 | 1627 | 2014 |
| The origin and evolution of mutations in acute myeloid leukemia JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ... Cell 150 (2), 264-278, 2012 | 1502 | 2012 |
| Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting H Matsushita, MD Vesely, DC Koboldt, CG Rickert, R Uppaluri, VJ Magrini, ... Nature 482 (7385), 400-404, 2012 | 1089 | 2012 |
| A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells BM Carreno, V Magrini, M Becker-Hapak, S Kaabinejadian, J Hundal, ... Science 348 (6236), 803-808, 2015 | 967 | 2015 |
| Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ... Nature 518 (7540), 552-555, 2015 | 586 | 2015 |
| Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ... Jama 314 (8), 811-822, 2015 | 317 | 2015 |
| pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens J Hundal, BM Carreno, AA Petti, GP Linette, OL Griffith, ER Mardis, ... Genome medicine 8 (1), 1-11, 2016 | 254 | 2016 |
| Temporally distinct PD-L1 expression by tumor and host cells contributes to immune escape T Noguchi, JP Ward, MM Gubin, CD Arthur, SH Lee, J Hundal, MJ Selby, ... Cancer immunology research 5 (2), 106-117, 2017 | 170 | 2017 |
| Genomic impact of transient low-dose decitabine treatment on primary AML cells JM Klco, DH Spencer, TL Lamprecht, SM Sarkaria, T Wylie, V Magrini, ... Blood, The Journal of the American Society of Hematology 121 (9), 1633-1643, 2013 | 140 | 2013 |
| U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing T Okeyo-Owuor, BS White, R Chatrikhi, DR Mohan, S Kim, M Griffith, ... Leukemia 29 (4), 909-917, 2015 | 111 | 2015 |
| Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ... Cell 183 (3), 818-834. e13, 2020 | 88 | 2020 |
| Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation H Celik, C Mallaney, A Kothari, EL Ostrander, E Eultgen, A Martens, ... Blood, The Journal of the American Society of Hematology 125 (4), 619-628, 2015 | 79 | 2015 |
| Genome modeling system: a knowledge management platform for genomics M Griffith, OL Griffith, SM Smith, A Ramu, MB Callaway, AM Brummett, ... PLoS computational biology 11 (7), e1004274, 2015 | 74 | 2015 |
| The prognostic effects of somatic mutations in ER-positive breast cancer OL Griffith, NC Spies, M Anurag, M Griffith, J Luo, D Tu, B Yeo, J Kunisaki, ... Nature communications 9 (1), 1-16, 2018 | 65 | 2018 |
| pVACtools: a computational toolkit to identify and visualize cancer neoantigens J Hundal, S Kiwala, J McMichael, CA Miller, H Xia, AT Wollam, CJ Liu, ... Cancer immunology research 8 (3), 409-420, 2020 | 59 | 2020 |
| Breast cancer neoantigens can induce CD8+ T-cell responses and antitumor immunity X Zhang, S Kim, J Hundal, JM Herndon, S Li, AA Petti, SD Soysal, L Li, ... Cancer immunology research 5 (7), 516-523, 2017 | 49 | 2017 |
| Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial R Lesurf, OL Griffith, M Griffith, J Hundal, L Trani, MA Watson, R Aft, ... Annals of Oncology 28 (5), 1070-1077, 2017 | 45 | 2017 |
| Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples EK Barnell, P Ronning, KM Campbell, K Krysiak, BJ Ainscough, LM Sheta, ... Genetics in Medicine 21 (4), 972-981, 2019 | 42 | 2019 |
| Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia M Griffith, OL Griffith, K Krysiak, ZL Skidmore, MJ Christopher, JM Klco, ... Experimental hematology 44 (7), 603-613, 2016 | 40 | 2016 |
